1,200 articles
Rama Khokha
Rama Khokha is a Canadian cancer biologist, Senior Scientist at the Princess Margaret Cancer Centre and University of Toronto professor, known for work on the tumor microenvironment and TIMP genes.
Ramaswamy Govindan
Ramaswamy Govindan is an Indian-born American medical oncologist at Washington University in St. Louis, known for lung cancer genomics research and as senior author of the sotorasib trial.
Rameen Beroukhim
Rameen Beroukhim is a cancer geneticist and neuro-oncologist at Dana-Farber, Harvard, and the Broad Institute, known for the 2010 pan-cancer copy-number survey and the GISTIC algorithm.
Ranjana H. Advani
Ranjana H. Advani is a medical oncologist who holds the Saul A. Rosenberg Professor of Lymphoma chair at Stanford University School of Medicine, treating Hodgkin and non-Hodgkin lymphoma.
Raymond N. DuBois
Raymond N. DuBois is an American physician-scientist known for defining the role of the enzyme COX-2 in colorectal cancer; he directs the Hollings Cancer Center in South Carolina.
Razelle Kurzrock
Razelle Kurzrock is an oncologist and precision-medicine researcher who directs the Center for Precision Oncology at the Medical College of Wisconsin and led the I-PREDICT and WINTHER trials.
Rebecca C. Fitzgerald
Rebecca C. Fitzgerald is a British clinician scientist and Professor of Cancer Prevention at the University of Cambridge, known for the Cytosponge test and the BEST3 trial for Barrett's esophagus.
Rein Saral
Rein Saral is an Estonian-born American oncologist and hematologist whose 1981 trial showed acyclovir prevents herpes infections in transplant patients, and who led bone-marrow transplant programs at Johns Hopkins and Emory.
Renata Pasqualini
Renata Pasqualini is a Brazilian-born cancer biologist known for co-developing in vivo phage display, a method for finding peptides that home to tumors, at Rutgers.
Renato Dulbecco
Renato Dulbecco (1914–2012) was an Italian-born American virologist and cancer researcher who shared the 1975 Nobel Prize for showing that tumor virus DNA integrates into host cells.
Renato V. Iozzo
Renato V. Iozzo is an Italian-trained physician-scientist and cell biologist who holds an endowed pathology chair at Thomas Jefferson University and defined the biology of small leucine-rich proteoglycans.
René Bernards
René Bernards (born 1953) is a Dutch molecular biologist and cancer geneticist at the Netherlands Cancer Institute in Amsterdam, known for pioneering functional genetic screens and the MammaPrint breast cancer prognosis test.
Rengaswamy Sankaranarayanan
Rengaswamy Sankaranarayanan (1952–2025) was an Indian cancer epidemiologist at IARC in Lyon whose trials in India established low-cost cervical cancer screening and single-dose HPV vaccination.
Riccardo Dalla-Favera
Riccardo Dalla-Favera, born 1951 in Legnano, Italy, is a cancer geneticist who identified the c-MYC and BCL6 oncogenes in B-cell lymphomas and directs Columbia University's Institute for Cancer Genetics.
Richard A. Van Etten
Richard A. Van Etten is an American hematologist-oncologist who directs the Chao Family Comprehensive Cancer Center at UC Irvine and developed the first mouse model of chronic myeloid leukemia.
Richard D. Gelber
Richard D. Gelber is a biostatistician at the Dana-Farber Cancer Institute and Harvard professor who has led breast cancer, leukemia, and AIDS trials since 1977 and developed the Q-TWiST and STEPP methods.
Richard Doll
Richard Doll (1912–2005) was a British physician and epidemiologist at Oxford who showed in 1950 that smoking causes lung cancer, and also established asbestos and radiation as cancer hazards.
Richard Gilbertson
Richard J. Gilbertson is a British cancer biologist and pediatric oncologist, Li Ka Shing Chair of Oncology at Cambridge, known for showing medulloblastoma comprises distinct molecular subtypes.
Richard Ho
Richard Ho is a pediatric hematologist-oncologist and stem cell transplant physician at Vanderbilt University Medical Center who received a Presidential Early Career Award in 2013 for his drug transporter research.
Richard I. Fisher
Richard I. Fisher is an American medical oncologist specializing in lymphoma who led the 1993 trial that kept CHOP the standard treatment for advanced non-Hodgkin's lymphoma.
Richard L. Schilsky
Richard L. Schilsky is an American medical oncologist at the University of Chicago who led a 2003 aspirin trial preventing colorectal adenomas and served as ASCO's first Chief Medical Officer.
Richard M. Stone
Richard M. Stone is an American hematologist-oncologist at Dana-Farber Cancer Institute in Boston, known for leading the RATIFY trial of midostaurin in acute myeloid leukemia.
Richard O. Hynes
Richard O. Hynes (1944–2026) was a cell and cancer biologist at MIT who discovered the fibronectin and integrin families of cell adhesion molecules, work honored with the 2022 Lasker Award.
Richard Pazdur
Richard Pazdur is an American medical oncologist who led the FDA's Oncology Center of Excellence and shaped United States cancer drug approval for over 25 years.
Richard Peto
Sir Richard Peto, born 1943, is a British medical statistician and epidemiologist at Oxford, known for tobacco epidemiology, the logrank test, meta-analysis of randomized trials, and Peto's paradox.
Richard S. Finn
Richard S. Finn is an American medical oncologist and professor at UCLA known for leading clinical development of palbociclib in breast cancer and atezolizumab plus bevacizumab in liver cancer.
Richard Schlegel
Richard Schlegel is an American viral oncologist and pathologist at Georgetown University Medical Center, known for work underpinning the HPV vaccine and for co-developing conditional reprogramming, a cell culture method.
Richard Sullivan (oncologist)
Richard Sullivan (born 1968) is a British oncologist, Professor of Cancer and Global Health at King's College London and Director of its Institute of Cancer Policy.
Rob Pieters
Rob Pieters is a Dutch pediatric oncologist at the Princess Máxima Center in Utrecht, known for drug resistance research and Interfant trials in infant leukemia.
Robbie G. Majzner
Robbie G. Majzner is a physician-scientist in pediatric oncology and cancer immunotherapy who directs the Pediatric and Young Adult Cancer Cell Therapy Program at Dana-Farber/Boston Children's Hospital.